fda semaglutide warning september 2025 U.S. sends drug advertising letters to Lilly, Novo, Hims Novo Nordisk Seeks FDA Approval

Abrahamse H, Hamblin MR

Weve prepared this blog to give you an idea of the scope of routine blood work so you can better understand how this powerful medical diagnostic works

This personalization reduces trial-and-error and helps avoid medications less likely to work for your biology

GLP-1s, more formally called GLP-1 receptor agonists , are a relatively new and emerging class of medications used to treat diabetes and/or obesity

GLP-1 & Ozempic Are Changing What America Eats: 7 Ways Food Brands Must Respond A quiet revolution is reshaping the American food market and it is not driven by a new diet trend, a celebrity influencer, or a government nutrition guideline

In-clinic visits cost less and include complimentary red light therapy